Natco pharma acquires Dash pharmaceuticals

0 138

NATCO Pharma Inc. USA, on Saturday, announced that it has completed the acquisition of a New Jersey-based entity Dash Pharmaceuticals LLC (“Dash”). It is expected that this development will provide the former with a platform to engage with its customers directly in the USA which is the largest pharmaceutical market in the world

The deal closed for 18 million US dollars has made Dash pharma a 100% wholly-owned subsidiary of NATCO Pharma and a step-down subsidiary of NATCO. Natco proposed the idea of acquiring Dash pharma in the mid of December last year.

Dash is a front-end pharmaceutical sales, marketing, and distribution company based in the United States that expects Net Sales of over USD 15 million for the fiscal year ending December 2021.

See the tweet:

Leave A Reply

Your email address will not be published.